May 10, 2017 / 11:14 AM / 3 months ago

BRIEF-Titan Pharmaceuticals reports Q1 loss per share $0.14

1 Min Read

May 10 (Reuters) - Titan Pharmaceuticals Inc:

* Titan pharmaceuticals reports first quarter 2017 financial results

* Q1 loss per share $0.14

* Titan Pharmaceuticals Inc - Titan is on track to submit an MAA to EMA in Q4 of 2017

* Titan Pharmaceuticals Inc - at March 31, 2017 titan had cash and cash equivalents of approximately $10.9 million

* Titan Pharmaceuticals Inc - company believes is sufficient to fund planned operations through Q2 of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below